New insider activity at Procter & Gamble ( (PG) ) has taken place on August 21, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jennifer L. Davis, the CEO of Health Care at Procter & Gamble, recently sold 8,596 shares of the company’s stock, amounting to a total transaction value of $1,351,892.
Spark’s Take on PG Stock
According to Spark, TipRanks’ AI Analyst, PG is a Outperform.
Procter & Gamble’s overall stock score reflects its strong financial performance and stable earnings outlook, despite technical resistance and macroeconomic challenges. The company’s strategic focus on innovation and shareholder returns supports its market position.
To see Spark’s full report on PG stock, click here.
More about Procter & Gamble
YTD Price Performance: -3.02%
Average Trading Volume: 8,150,069
Technical Sentiment Signal: Buy
Current Market Cap: $371B